comparemela.com

Latest Breaking News On - Society of investigative dermatology - Page 1 : comparemela.com

Azitra, Inc Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting

ATR-04 is in development for epidermal growth factor receptor inhibitor -induced dermal toxicity, which affects approximately 150,000 patients in the US Reduces methicillin-resistant S. aureus by.

Azitra, Inc (AZTR) Presents Positive Preclinical Data from ATR-04

Azitra, Inc (AZTR) Presents Positive Preclinical Data from ATR-04
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Azitra, Inc to Present New Data at Three Upcoming Scientific Conferences in May 2024

18.04.2024 - Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced it will be presenting promising new preclinical data from its platform built (or . Seite 1

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.